Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma | PLOS ONE
![Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-59031-1/MediaObjects/41598_2020_59031_Fig1_HTML.png)
Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports
![Marker nowotworowy CEA: normy i interpretacja wyników. Kiedy wykonać badanie antygenu CEA i jak się do niego przygotować? | Strona Zdrowia Marker nowotworowy CEA: normy i interpretacja wyników. Kiedy wykonać badanie antygenu CEA i jak się do niego przygotować? | Strona Zdrowia](https://d-art.ppstatic.pl/kadry/k/r/1/44/4a/5e1f0edab3d16_o_large.jpg)
Marker nowotworowy CEA: normy i interpretacja wyników. Kiedy wykonać badanie antygenu CEA i jak się do niego przygotować? | Strona Zdrowia
![Ultrasensitive Point‐of‐Care Test for Tumor Marker in Human Saliva Based on Luminescence‐Amplification Strategy of Lanthanide Nanoprobes - Zhou - 2021 - Advanced Science - Wiley Online Library Ultrasensitive Point‐of‐Care Test for Tumor Marker in Human Saliva Based on Luminescence‐Amplification Strategy of Lanthanide Nanoprobes - Zhou - 2021 - Advanced Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9c0993bc-1948-40a1-9dc9-11e86711f61b/advs2223-fig-0006-m.jpg)
Ultrasensitive Point‐of‐Care Test for Tumor Marker in Human Saliva Based on Luminescence‐Amplification Strategy of Lanthanide Nanoprobes - Zhou - 2021 - Advanced Science - Wiley Online Library
![Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen](https://www.intechopen.com/media/chapter/46036/media/fig3.png)
Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen
![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-gr2.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
![CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01431-9/MediaObjects/41416_2021_1431_Fig1_HTML.png)